Viridian Therapeutics, Inc. (VRDN) Misses Q2 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/2/2026
- S&P 500 ends down; Apple dips ahead of quarterly report
- Apple beats quarterly estimates for profit and revenue
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 7% as Iran signals openness to peace talks
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
| (NASDAQ: VRDN) | Delayed: 25.30 +0.63 (2.55%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $24.67 | 52 Week High | $ | |||
| Open | $24.45 | 52 Week Low | $ | |||
| Day High | $25.58 | P/E | N/A | |||
| Day Low | $23.97 | EPS | $ | |||
| Volume | 3,391,269 | |||||
